Networks and Partners
The Cervical Cancer Action network aims to maximise the impact of those working to stop cervical cancer, with a membership including Cancer Research UK, the American Cancer Society, PATH, WHO and UICC.
Cervical Cancer Action works specifically to:
- Advocate on global, regional, and national levels for the necessary political and financial commitment to:
- Raise awareness and demand for new cervical cancer prevention technologies.
- Expand resources committed to cervical cancer prevention.
- Expedite regulatory approval and issuance of guidelines for use of new prevention and treatment tools.
- Encourage affordable pricing and adequate supplies from the manufacturers.
- Promote a comprehensive approach to cervical cancer prevention focused on the most appropriate use of new and existing technologies.
- Facilitate better communication among partner organizations and the larger community of cervical cancer organizations to improve knowledge and share lessons learned about current activities and results.
- Foster the efficient and effective use of resources through information sharing and strategic partnering between members and other stakeholder organizations.
- Monitor and build accountability among stakeholders to catalyze efforts in the global elimination of cervical cancer.
The Breast Cancer Initiative 2.5 (BCI2.5) represents a new commitment to unite the global breast cancer community behind a common goal to make breast health a global priority and reduce disparities in breast cancer outcomes worldwide. The initiative began as a call for action in 2014 supported by UICC, the American Cancer Society, and Susan G. Komen.
“As the most common cancer among women, breast cancer must be addressed at the global level. Progress made in high income countries has not yet been mirrored in low and middle-income countries. These differences represent a real and tangible opportunity to improve women’s lives."
-Benjamin O. Anderson, Chair and Director of Breast Health Global Initiative, a founding member of BCI2.5
Since that initial pledge, the BCI2.5 has been engaging partners around the world, assessing need, identifying priorities and defining a strategy to meet this goal. Its consensus-based approach empowers regional champions to bring about change with the aid of its analytic, assessment and planning tools, educational materials and implementation science research methodology. The BCI2.5 delivers evidence-based technical expertise and a resource-stratified approach to improving breast health services and care at any resource level. The initiative is inclusive and encourages organizations, institutions and countries to connect and join the effort.
The Global Access to Pain Relief Initiative (GAPRI) addresses target 8 of the World Cancer Declaration to make essential pain medicines universally available by 2020.
GAPRI builds capacity through action that addresses the following objectives:
- Empowering governments to take the lead in expanding access to pain relief and palliative care
- Mainstreaming the issue of pain treatment and palliative care in the global health and drug regulation agenda
- Calling for integration pain management and palliative care into national cancer control plans and supporting strengthening of the health system response.
Cochrane is a global independent network of more than 30,000 researchers, professionals, patients, carers, and people interested in health. It produces reviews that summarise the best available evidence generated through research to inform decisions about health. In 2016, UICC and Cochrane signed a Memorandum of Understanding to develop and implement joint activities that support evidence-based advocacy for cancer control.
For more information about Cochrane, please visit www.cochranelibrary.com.